Page 98 - 《中国药房》2023年2期

ption-Drug-Coverage/PrescriptionDrugCovContra/Down‐ BMC Med，2021，19（1）：262.
loads/Memo-Contract-Year-2020-Medication-Therapy- [32] GARLAND C T，GUÉNETTE L，KRÖGER E，et al. A
Management-MTM-Program-Submission-v-041019-.pdf. new care model reduces polypharmacy and potentially in‐
[21] CMS. State operations manual appendix PP：guidance to appropriate medications in long-term care[J]. J Am Med
surveyors for long term care facilities[EB/OL].（2020-08- Dir Assoc，2021，22（1）：141-147.
01）[2022-07-05].https：//www.cms.gov/Medicare/Provider- [33] THIRUCHELVAM K，HASAN S S，PUDMENZKY A，et
Enrollment-and-Certification/GuidanceforLawsAndRegu‐ al. Development，validation and evaluation of an online
lations/Downloads/Appendix-PP-State-Operations-Manual. medication review tool（MedReview）[J]. PLoS One，
pdf. 2022，17（6）：e0269322.
[22] BROWN C H. The consultant pharmacist’s role in long- [34] TASAI S，KUMPAT N，DILOKTHORNSAKUL P，et al.
term care facilities[J]. J Pharm Pract，1988，1（3）：166-172. Impact of medication reviews delivered by community
[23] SIMONSON W. Significant changes in CMS pharmacy pharmacist to elderly patients on polypharmacy：a meta-
services F-Tags for long-term care facilities[J]. Geriatr analysis of randomized controlled trials[J]. J Patient Saf，
Nurs，2018，39（1）：112-114. 2021，17（4）：290-298.
[24] CMS. Medicare part D medication therapy management [35] SCHINDLER E，HOHMANN C，CULMSEE C. Medica‐
（MTM）programs：fact sheet[EB/OL]. [2022-07-05]. tion review by community pharmacists for type 2 diabetes
https：//www.cms.gov/Medicare/Prescription-Drug-Coverage/ patients in routine care：results of the DIATHEM-study[J].
PrescriptionDrugCovContra/Downloads/CY2019-MTM- Front Pharmacol，2020，11：1176.
Fact-Sheet.pdf. [36] ROSLI M R，NEOH C F，WU D B，et al. Evaluation of
[25] NHS. Five year forward view[EB/OL]. [2022-07-05]. home medication review for patients with type 2 diabetes
https：//www.england.nhs.uk/wp-content/uploads/2014/10/ mellitus by community pharmacists：a randomised con‐
5yfv-web.pdf. trolled trial[J]. Pharm Pract（Granada），2021，19（3）：2397.
[26] NHS. Medicines optimisation in care homes [EB/OL]. [37] ROSLI M R，WU D B C，NEOH C F，et al. Economic
[2022-07-05].https：//www.england.nhs.uk/wp-content/up‐ evaluation of home medication review by community
loads/2018/03/medicines-optimisation-in-care-homes-pro- pharmacists（HMR-CP）for patients with type 2 diabetes
gramme-overview.pdf. mellitus（T2DM）[J]. J Med Econ，2021，24（1）：730-740.
[27] Australia Government Department of Health and Aged [38] KARI H N，ÄIJÖ-JENSEN N，KORTEJÄRVI H，et al. Ef‐
Care. Residential medication management review[EB/ fectiveness and cost-effectiveness of a people-centred care
OL].[2022-07-25]. https：//www.ppaonline.com.au/wp- model for community-living older people versus usual
content/uploads/2020/04/RMMR-Program-Rules-COVID- care：a randomised controlled trial[J]. Res Social Adm
19.pdf. Pharm，2022，18（6）：3004-3012.
[28] PSA. Guidelines for quality use of medicines（QUM） ser‐ [39] SALARI P，O’MAHONY C，HENRARD S，et al. Cost-
vices[EB/OL]. [2022-07-05]. https：//www. ppaonline. com. effectiveness of a structured medication review approach
au/wp-content/uploads/2020/04/PSA-Guidelines-for-Quality- for multimorbid older adults：within-trial analysis of the
Use-of-Medicines-QUM-services.pdf. OPERAM study[J]. PLoS One，2022，17（4）：e0265507.
[29] PSA. Guidelines for pharmacists providing residential [40] 刘清扬，白向荣，王可，等. 门诊和居家患者药物相关问
medication management review（RMMR） and quality use 题分类系统的研制[J]. 药物不良反应杂志，2021，23（3）：
of medicines （QUM） services[EB/OL]. [2022-07-05]. 120-127.
https：//www. ppaonline. com. au/wp-content/uploads/2019/ [41] 上海市医院协会临床药事管理专业委员会，上海市药学
01/PSA-RMMR-and-QUM-Guidelines.pdf. 会医院药学专业委员会，廖赟，等. 《中国药物相关问题
[30] Australia Government Department of Health and Aged 分类系统（V1.0）》使用标准[J]. 中华预防医学杂志，
Care. Program rules quality use of medicines[EB/OL]. 2022，56（8）：1042-1049.
[2022-07-05]. https：//www. ppaonline. com. au/wp-content/ [42] 刘思彤，杨丽娟，李全志，等. 老年高血压患者健康管理
uploads/2020/04/QUM-Program-Rules-COVID-19. pdf. 软件需求调研[J]. 中国医院药学杂志，2022，42（5）：
[31] MCCAHON D，DENHOLM R E，HUNTLEY A L，et al. 560-563.
Development of a model of medication review for use in （收稿日期：2022-10-05 修回日期：2022-12-27）
clinical practice：Bristol medication review model[J]. （编辑：孙 冰）

· 216 · China Pharmacy 2023 Vol. 34 No. 2 中国药房 2023年第34卷第2期